The FDA Thursday approved the ARC-EX System designed to restore mobility after spinal cord injury by delivering programmed ...

With the FDA's new requirements for premarket submission and ongoing monitoring by medical device manufacturers in place, ...

Children's National Hospital and the FDA announced a collaboration to develop regulatory science tools (RSTs) for pediatric ...

A novel nanobody-based immunosensor, designed to function stably in undiluted biological fluids and harsh conditions, has ...

With approval, the company can begin commercializing the device in the U.S. in 2025.

and supporting novel medical devices that address unmet clinical needs and deliver lasting impact. For more information, visit our website www.inquismedical.com or follow us on LinkedIn.

significantly reducing their costs to be comparable or even lower than that of current medical devices." To conclude, this novel solar cell-based device has the potential to accelerate the ...

Latham & Watkins were able to defend cosmetic device patents on behalf of Serendia LLC at the U.S. International Trade ...

DUBLIN--(BUSINESS WIRE)--CroíValve, a pioneering medical device company focused on the development of a novel transcatheter device for the treatment of severe+ tricuspid regurgitation (TR ...

The innovations cover novel diagnostic tools, medical devices, healthcare delivery and alternative technologies. The ‘Swasth ...